Morningstar's CSPC Pharmaceutical Group Ltd Stock Analysis
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
CSPC Pharmaceutical Group Ltd's Company Profile
CSPC Pharmaceutical Group, or CSPC, is one of the largest drug manufacturers in China. The company has a diversified portfolio of generic drugs, bulk drugs, and drugs with improved formulations. Its R&D pipeline is primarily focused on cardio-cerebrovascular diseases, digestion and metabolic diseases, oncology, neurology, and anti-infectives.
Shijiazhuang, 050035, China, People's Republic of